Gainers
Senti Biosciences, Inc. (NASDAQ: SNTI) shares surged 120.8% to $0.6450 in pre-market trading after the company reported a new strategic collaboration with Celest Therapeutics for the clinical development of SENTI-301A in China.
Tharimmune, Inc. (NASDAQ: THAR) shares rose 76.8% to $0.2790 in pre-market trading as the company disclosed the execution of an exclusive worldwide licensing agreement with Avior Inc. d/b/a Avior Bio, LLC to develop, market and commercialize a clinical-stage asset, AV104.
TransMedics Group, Inc. (NASDAQ: TMDX) shares rose 39.7% to $56.16 in pre-market trading after the company reported better-than-expected third-quarter sales results and issued strong FY23 revenue guidance.
GSE Systems, Inc. (NASDAQ: GVP) rose 18.3% to $3.88 in pre-market trading. GSE Solutions was recently awarded a $4.2 million contract from a large utility for nuclear power plant engineering work.
Unisys Corporation (NYSE: UIS) shares climbed 17.7% to $3.40 in pre-market trading after the company posted upbeat third-quarter results ...